Strides Pharma [STAR] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Strides Pharma Science Ltd.

NSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Strides Pharma Science Ltd. wins in 11 metrics, Divi's Laboratories Ltd. wins in 9 metrics, with 0 ties. Strides Pharma Science Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Strides Pharma Science Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 19.26 67.11 Strides Pharma Science Ltd.
Price-to-Book Ratio 3.57 10.82 Strides Pharma Science Ltd.
Debt-to-Equity Ratio 65.79 0.58 Divi's Laboratories Ltd.
PEG Ratio 0.11 4.63 Strides Pharma Science Ltd.
EV/EBITDA 12.80 48.63 Strides Pharma Science Ltd.
Profit Margin (TTM) 10.82% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) 15.51% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) 15.51% 29.65% Divi's Laboratories Ltd.
Return on Equity 138.93% 14.64% Strides Pharma Science Ltd.
Return on Assets (TTM) 59.41% 12.94% Strides Pharma Science Ltd.
Free Cash Flow (TTM) $4.42B $2.15B Strides Pharma Science Ltd.
Dividend Yield 0.74% 0.91% Divi's Laboratories Ltd.
1-Year Return 19.61% -0.43% Strides Pharma Science Ltd.
Price-to-Sales Ratio (TTM) 2.09 16.18 Strides Pharma Science Ltd.
Enterprise Value $108.98B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 2.31 15.86 Strides Pharma Science Ltd.
Gross Profit Margin (TTM) 61.25% 63.71% Divi's Laboratories Ltd.
Revenue per Share (TTM) $513 $388 Strides Pharma Science Ltd.
Earnings per Share (Diluted) $55.51 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) 0.26 0.19 Divi's Laboratories Ltd.

Strides Pharma Science Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

STAR
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Strides Pharma Science Ltd.2.82%7.91%-5.93%21.68%24.92%19.09%
Divi's Laboratories Ltd.-0.44%1.34%-2.25%8.85%4.11%4.17%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Strides Pharma Science Ltd.19.61%162.17%36.49%3.15%222.14%318.10%
Divi's Laboratories Ltd.-0.43%85.44%58.15%496.33%1,610.60%10,946.76%

Performance & Financial Health Analysis: Strides Pharma Science Ltd. vs Divi's Laboratories Ltd.

MetricSTARDIVISLAB
Market Information
Market Cap i₹98.28B₹1.69T
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i306,327253,443
90 Day Avg. Volume i294,978283,911
Last Close₹1,085.30₹6,608.50
52 Week Range₹768.65 - ₹1,231.00₹5,636.50 - ₹7,071.50
% from 52W High-11.84%-6.55%
All-Time High₹1,675.00 (Oct 14, 2024)₹7,071.50 (Jul 08, 2025)
% from All-Time High-35.21%-6.55%
Growth Metrics
Quarterly Revenue Growth0.04%0.12%
Quarterly Earnings Growth1.30%-0.01%
Financial Health
Profit Margin (TTM) i0.11%0.24%
Operating Margin (TTM) i0.16%0.30%
Return on Equity (TTM) i1.39%0.15%
Debt to Equity (MRQ) i65.790.58
Cash & Liquidity
Book Value per Share (MRQ)₹299.06₹580.95
Cash per Share (MRQ)₹24.68₹122.95
Operating Cash Flow (TTM) i₹36.02B₹19.67B
Levered Free Cash Flow (TTM) i₹35.93B₹21.91B
Dividends
Last 12-Month Dividend Yield i0.74%0.91%
Last 12-Month Dividend i₹6.50₹60.00

Valuation & Enterprise Metrics Analysis: Strides Pharma Science Ltd. vs Divi's Laboratories Ltd.

MetricSTAR (Apr 24, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i19.2667.11
Forward P/E i14.7353.75
PEG Ratio i0.114.63
Price to Sales (TTM) i2.0916.18
Price to Book (MRQ) i3.5710.82
Market Capitalization
Market Capitalization i₹98.28B₹1.69T
Enterprise Value i₹108.98B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i2.3115.86
Enterprise to EBITDA i12.8048.63
Risk & Other Metrics
Beta i0.260.19
Book Value per Share (MRQ) i₹299.06₹580.95

Financial Statements Comparison: Strides Pharma Science Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSTAR (2025)DIVISLAB (2025)
Revenue/Sales i43.92B93.25B
Cost of Goods Sold i21.34B38.70B
COGS % of Revenue i48.6%41.5%
Gross Profit i22.58B54.55B
Gross Margin i51.4%58.5%
Research & Development iN/A270.00M
Operating Income (EBIT) i5.80B25.71B
Operating Margin i13.2%27.6%
EBITDA i7.90B33.19B
EBITDA Margin i18.0%35.6%
Pre-Tax Income i4.87B29.16B
Pre-Tax Income % of Revenue i11.1%31.3%
Income Tax i775.16M7.25B
Income Tax % of Revenue i1.8%7.8%
Net Income (Profit) i35.98B21.91B
Profit Margin i81.9%23.5%

Balance Sheet & Liquidity Metrics

MetricSTAR (2025)DIVISLAB (2025)
Cash & Equivalents i1.13B4.15B
Total Current Assets i31.02B100.81B
Total Current Assets % of Revenue i70.6%108.1%
Total Current Liabilities i25.92B14.52B
Total Current Liabilities % of Revenue i59.0%15.6%
Long-Term Debt i6.23B20.00M
Long-Term Debt % of Revenue i14.2%0.0%
Total Shareholders Equity i25.86B149.69B
Retained Earnings i4.59B134.00B
Retained Earnings % of Revenue i10.4%143.7%
Property, Plant & Equipment i8.81B3.19B

Cash Flow Statement Comparison

MetricSTAR (2025)DIVISLAB (2025)
Operating Cash Flow i36.02B19.67B
Operating Cash Flow % of Revenue i82.0%21.1%
Capital Expenditures i681.03M-14.38B
Free Cash Flow i4.42B2.15B
FCF Margin i10.1%2.3%
Debt Repayment i-3.20BN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSTARDIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i92.17M265.47M
Float Shares i56.69M117.72M
% Held by Insiders i30.78%52.04%
% Held by Institutions i26.99%28.65%
% Held by Public i42.23%19.31%

Dividend Analysis & Yield Comparison: Strides Pharma Science Ltd. vs Divi's Laboratories Ltd.

MetricSTARDIVISLAB
Last 12-Month Dividend i₹6.50₹60.00
Last 12-Month Dividend Yield i0.74%0.91%
3-Year Avg Annual Dividend i₹2.67₹50.00
3-Year Avg Dividend Yield i0.32%0.70%
3-Year Total Dividends i₹8.00₹150.00
Ex-Dividend DateJul 22, 2025Jul 25, 2025